• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diagnostic Pathology of Tumors of Peripheral Nerve.周围神经肿瘤的诊断病理学。
Neurosurgery. 2021 Feb 16;88(3):443-456. doi: 10.1093/neuros/nyab021.
2
Methylation-based classification of benign and malignant peripheral nerve sheath tumors.基于甲基化的良性和恶性周围神经鞘瘤分类。
Acta Neuropathol. 2016 Jun;131(6):877-87. doi: 10.1007/s00401-016-1540-6. Epub 2016 Feb 8.
3
Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.周围神经鞘瘤的病理学:诊断概述及部分诊断问题的更新。
Acta Neuropathol. 2012 Mar;123(3):295-319. doi: 10.1007/s00401-012-0954-z. Epub 2012 Feb 12.
4
Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.神经纤维瘤/神经鞘瘤的分子分析鉴定出常见的单体型 22 和 α-T-连环蛋白/CTNNA3 是一种新的候选肿瘤抑制基因。
Am J Pathol. 2016 Dec;186(12):3285-3296. doi: 10.1016/j.ajpath.2016.08.019. Epub 2016 Oct 17.
5
Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.18 氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在鉴别 1 型神经纤维瘤病相关的良性神经纤维瘤与恶性外周神经鞘瘤中的作用。
Neurosurgery. 2009 Oct;65(4 Suppl):A160-70. doi: 10.1227/01.NEU.0000337597.18599.D3.
6
Peripheral nerve tumors.周围神经肿瘤
Handb Clin Neurol. 2024;201:251-271. doi: 10.1016/B978-0-323-90108-6.00016-8.
7
Practical Approach to Histological Diagnosis of Peripheral Nerve Sheath Tumors: An Update.外周神经鞘瘤组织学诊断的实用方法:最新进展
Diagnostics (Basel). 2022 Jun 14;12(6):1463. doi: 10.3390/diagnostics12061463.
8
Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.神经纤维瘤/雪旺细胞瘤混合瘤在神经鞘瘤病和神经纤维瘤病患者中较为多见。
Am J Surg Pathol. 2012 May;36(5):702-9. doi: 10.1097/PAS.0b013e31824d3155.
9
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.非典型神经纤维瘤表现出与良性周围神经鞘瘤实体接近的独特表观遗传特征。
Neuro Oncol. 2023 Sep 5;25(9):1644-1655. doi: 10.1093/neuonc/noad053.
10
Colocalized cellular schwannoma and plexiform neurofibroma in the absence of neurofibromatosis. Case report.无神经纤维瘤病情况下的细胞性施万细胞瘤与丛状神经纤维瘤并存。病例报告。
J Neurosurg. 2007 Aug;107(2):435-9. doi: 10.3171/JNS-07/08/0435.

引用本文的文献

1
Malignant peripheral nerve sheath tumor of the right forearm: Case report.右前臂恶性周围神经鞘膜瘤:病例报告
Int J Surg Case Rep. 2025 Aug 13;135:111800. doi: 10.1016/j.ijscr.2025.111800.
2
Epigenetic Mechanisms in Neurofibromatosis Types 1 and 2.1型和2型神经纤维瘤病中的表观遗传机制
Epigenomes. 2025 Aug 14;9(3):30. doi: 10.3390/epigenomes9030030.
3
Cervical Schwannoma: Diagnosis and Treatment in a Second-Level Hospital in Mexico.颈椎神经鞘瘤:墨西哥一家二级医院的诊断与治疗
Cureus. 2025 Jul 7;17(7):e87481. doi: 10.7759/cureus.87481. eCollection 2025 Jul.
4
New models for MPNST: establishment and comprehensive characterization of two tumor cell lines.MPNST的新模型:两种肿瘤细胞系的建立与全面表征
Cancer Cell Int. 2025 Jul 18;25(1):268. doi: 10.1186/s12935-025-03845-4.
5
Crosslinking Surgical Oncology and the Assessments of Hernia Sac Tissues With Malignant Transformations.交联手术肿瘤学与恶性转化疝囊组织的评估
Cureus. 2025 May 18;17(5):e84317. doi: 10.7759/cureus.84317. eCollection 2025 May.
6
A schwannoma look-alike: solitary fibrous tumor of the cauda equina. Illustrative case.一种酷似神经鞘瘤的疾病:马尾神经孤立性纤维瘤。病例说明
J Neurosurg Case Lessons. 2025 Jun 16;9(24). doi: 10.3171/CASE2585.
7
Extradural malignant melanotic nerve sheath tumor of the lumbosacral spine: a diagnostic and surgical challenge.腰骶部脊柱硬膜外恶性黑色素性神经鞘瘤:诊断与手术挑战
Ann Med Surg (Lond). 2025 May 12;87(6):3940-3944. doi: 10.1097/MS9.0000000000003327. eCollection 2025 Jun.
8
Resection of a rare lumbar epithelioid schwannoma.罕见的腰椎上皮样神经鞘瘤切除术。
Surg Neurol Int. 2025 May 16;16:188. doi: 10.25259/SNI_267_2025. eCollection 2025.
9
An Unusual Location for Orbital Schwannoma: A Case Report.眼眶神经鞘瘤的一个不寻常位置:病例报告
Clin Case Rep. 2025 Jun 2;13(6):e70567. doi: 10.1002/ccr3.70567. eCollection 2025 Jun.
10
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation.伴有神经分化的脊髓内ASPSCR1::TFE3重排肿瘤
Brain Tumor Pathol. 2025 May 27. doi: 10.1007/s10014-025-00502-6.

本文引用的文献

1
Selumetinib in Children with Inoperable Plexiform Neurofibromas.索拉非尼治疗不可手术的丛状神经纤维瘤患儿的疗效观察。
N Engl J Med. 2020 Apr 9;382(15):1430-1442. doi: 10.1056/NEJMoa1912735. Epub 2020 Mar 18.
2
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors.神经纤维瘤/雪旺细胞瘤混合性神经鞘瘤中可靶向的 ERBB2 突变。
J Clin Invest. 2020 May 1;130(5):2488-2495. doi: 10.1172/JCI130787.
3
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.多中心、前瞻性、II 期和生物标志物研究:大剂量贝伐珠单抗作为神经纤维瘤病 2 型和进展性前庭神经鞘瘤患者的诱导治疗。
J Clin Oncol. 2019 Dec 10;37(35):3446-3454. doi: 10.1200/JCO.19.01367. Epub 2019 Oct 18.
4
Intracranial cellular schwannomas: a clinicopathological study of 20 cases.颅内细胞性 schwann 瘤:20 例临床病理研究。
Histopathology. 2020 Jan;76(2):275-282. doi: 10.1111/his.13967. Epub 2019 Nov 13.
5
LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases.LZTR1 促进 RAS-GTPases 的多泛素化和降解。
Cell Death Differ. 2020 Mar;27(3):1023-1035. doi: 10.1038/s41418-019-0395-5. Epub 2019 Jul 23.
6
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas.低突变负担和频繁缺失 CDKN2A/B 和 SMARCA2,但不缺失 PRC2,定义了良性神经纤维瘤病 1 相关非典型神经纤维瘤。
Neuro Oncol. 2019 Aug 5;21(8):981-992. doi: 10.1093/neuonc/noz028.
7
Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing.利用 2777 名经分子检测个体的数据库,确定神经纤维瘤病 2 现行诊断标准的缺陷。
Genet Med. 2019 Jul;21(7):1525-1533. doi: 10.1038/s41436-018-0384-y. Epub 2018 Dec 7.
8
Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA.通过 NGS 和 MLPA 鉴定的一系列神经纤维瘤病 1 型 (NF1) 突变的表型表达。
J Neurol Sci. 2018 Dec 15;395:95-105. doi: 10.1016/j.jns.2018.10.006. Epub 2018 Oct 4.
9
Recurrent Genomic Alterations in Soft Tissue Perineuriomas.软组织神经鞘瘤中的复发性基因组改变。
Am J Surg Pathol. 2018 Dec;42(12):1708-1714. doi: 10.1097/PAS.0000000000001169.
10
Next Generation Sequencing of Sporadic Vestibular Schwannoma: Necessity of Biallelic NF2 Inactivation and Implications of Accessory Non-NF2 Variants.散发性前庭神经鞘瘤的下一代测序:NF2 双等位基因失活的必要性及辅助非 NF2 变异体的影响。
Otol Neurotol. 2018 Oct;39(9):e860-e871. doi: 10.1097/MAO.0000000000001932.

周围神经肿瘤的诊断病理学。

Diagnostic Pathology of Tumors of Peripheral Nerve.

机构信息

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

School of Medicine, University of Tunis El Manar, Tunis, Tunisia.

出版信息

Neurosurgery. 2021 Feb 16;88(3):443-456. doi: 10.1093/neuros/nyab021.

DOI:10.1093/neuros/nyab021
PMID:33588442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7884141/
Abstract

Neoplasms of the peripheral nervous system represent a heterogenous group with a wide spectrum of morphological features and biological potential. They range from benign and curable by complete excision (schwannoma and soft tissue perineurioma) to benign but potentially aggressive at the local level (plexiform neurofibroma) to the highly malignant (malignant peripheral nerve sheath tumors [MPNST]). In this review, we discuss the diagnostic and pathologic features of common peripheral nerve sheath tumors, particularly those that may be encountered in the intracranial compartment or in the spine and paraspinal region. The discussion will cover schwannoma, neurofibroma, atypical neurofibromatous neoplasms of uncertain biological potential, intraneural and soft tissue perineurioma, hybrid nerve sheath tumors, MPNST, and the recently renamed enigmatic tumor, malignant melanotic nerve sheath tumor, formerly referred to as melanotic schwannoma. We also discuss the diagnostic relevance of these neoplasms to specific genetic and familial syndromes of nerve, including neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis. In addition, we discuss updates in our understanding of the molecular alterations that represent key drivers of these neoplasms, including neurofibromatosis type 1 and type 2, SMARCB1, LZTR1, and PRKAR1A loss, as well as the acquisition of CDKN2A/B mutations and alterations in the polycomb repressor complex members (SUZ12 and EED) in the malignant progression to MPNST. In summary, this review covers practical aspects of pathologic diagnosis with updates relevant to neurosurgical practice.

摘要

外周神经系统肿瘤是一组具有广泛形态特征和生物学潜能的异质性肿瘤。它们的范围从可通过完全切除治愈的良性肿瘤(神经鞘瘤和软组织神经鞘瘤)到良性但局部侵袭性较高的肿瘤(丛状神经纤维瘤),再到高度恶性的肿瘤(恶性外周神经鞘瘤[MPNST])。在这篇综述中,我们讨论了常见外周神经鞘瘤的诊断和病理特征,特别是那些可能在颅内或脊柱和脊柱旁区域遇到的肿瘤。讨论将涵盖神经鞘瘤、神经纤维瘤、生物学潜能不确定的非典型神经纤维瘤性肿瘤、神经内和软组织神经鞘瘤、混合性神经鞘瘤、MPNST 以及最近重新命名的神秘肿瘤,恶性黑色素性神经鞘瘤,以前称为黑色素性神经鞘瘤。我们还讨论了这些肿瘤与特定的神经遗传和家族综合征的诊断相关性,包括神经纤维瘤病 1 型、神经纤维瘤病 2 型和神经鞘瘤病。此外,我们还讨论了我们对这些肿瘤关键驱动因素的分子改变的理解的最新进展,包括神经纤维瘤病 1 型和 2 型、SMARCB1、LZTR1 和 PRKAR1A 缺失,以及 CDKN2A/B 突变的获得和多梳抑制复合物成员(SUZ12 和 EED)在外周神经鞘瘤恶性进展中的改变。总之,这篇综述涵盖了与神经外科实践相关的病理诊断的实用方面。